CN107522629A - A kind of preparation method of aspartic acid ornithine - Google Patents

A kind of preparation method of aspartic acid ornithine Download PDF

Info

Publication number
CN107522629A
CN107522629A CN201710945408.XA CN201710945408A CN107522629A CN 107522629 A CN107522629 A CN 107522629A CN 201710945408 A CN201710945408 A CN 201710945408A CN 107522629 A CN107522629 A CN 107522629A
Authority
CN
China
Prior art keywords
aspartic acid
ornithine
acid ornithine
preparation
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710945408.XA
Other languages
Chinese (zh)
Inventor
王章跃
沙其强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJIAN JINSHAN BIOMEDICINE Co Ltd
Original Assignee
FUJIAN JINSHAN BIOMEDICINE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUJIAN JINSHAN BIOMEDICINE Co Ltd filed Critical FUJIAN JINSHAN BIOMEDICINE Co Ltd
Priority to CN201710945408.XA priority Critical patent/CN107522629A/en
Publication of CN107522629A publication Critical patent/CN107522629A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a kind of preparation method of aspartic acid ornithine, cationic ion-exchange resin is utilized by raw material of L ornithine hydrochlorides, by adsorbing, eluting, obtaining the free L ornithine aqueous solution except ammonia, the L ornithines aqueous solution with L asparatates by reacting, crystallize, it is refined after, dry after obtain finished product.The preparation method reaction condition of the present invention is simple, and cost is low, is adapted to industrialized production, obtained aspartic acid ornithine purity height and high income.

Description

A kind of preparation method of aspartic acid ornithine
Technical field
The present invention relates to pharmaceutical chemistry technical field, more particularly to a kind of preparation method of aspartic acid ornithine.
Background technology
The salt that aspartic acid ornithine is L-ASPARTIC ACID and L-Orn after chemical reaction is formed, chemical entitled (S)- 2,5- diaminovaleric acids-(S) -2- aminosuccinic acid salt, molecular formula C9H19N3O6, molecular weight 265.27, structural formula is:
Aspartic acid ornithine is that one kind treats liver disease drug, especially suitable for the central nervous system caused by liver disease The releasing for symptom of uniting and the rescue of hepatic coma.
At present, the preparation method of aspartic acid ornithine mainly has following several method:
Patent DE4020980, EP0464325A3 and EP0464325B1 of German Degussa company, use arginase L-arginine is converted into L-Orn, then reacts with ASPARTIC ACID to obtain aspartic acid ornithine again.This method makes Arginase is expensive, and cost is higher, is unsuitable for industrialized production.
1967, the BP GB1067742 of Japanese KYOWA HAKKO KOGYO applications, using strong acidic ion Exchanger resin dissociates L-ornithine hydrochloride, then obtains aspartic acid ornithine one into salt, crystallization with L-ASPARTIC ACID reaction Hydrate, this method yield is extremely low and is crystallization water-bound.
The Chinese patent CN101100435A of Shanghai Yifurui Industry Co., Ltd's application, L-Orn sulfate is dissolved in In water, add ASPARTIC ACID, add dissolving, with barium hydroxide and L-Orn sulfate in sulfuric acid, cold filtration, Barium sulfate is removed, then the barium ions of residual is chelated with D403 chelating resins, chelating resin is filtered to remove, concentrates, decolourize, crystallize To finished product.This method introduces the barium ions of severe toxicity, is unsuitable for industrialized production.
The Chinese patent CN102475697A of Xiong Guoyu applications, disclose a kind of with nanofiltration processing L-aminobutanedioic acid bird ammonia Acid reaction liquid, desalination, concentration, recrystallization, obtain the method for aspartate for injection ornithine.The nanofiltration that this method uses Condition is harsh, and cost is high, is not suitable for industrialized production.
The Chinese patent CN102964261A of the applications such as Xiao Wenhui, using electrodialysis methods, using charged ion in electric current The lower mobile principle of effect removes the chlorion in ornithine hcl 99, is then made with L-ASPARTIC ACID into salt.This method Weak point is electric dialyzator desalination harshness, and catholyte process produces inflammable and explosive hydrogen, is not suitable for industrialized production.
The Chinese patent CN103864634B of Changzhou Lanling Pharmaceutical Co., Ltd.'s application, by the L-ornithine hydrochloride aqueous solution The L-Orn aqueous solution is obtained through 732 type storng-acid cation exchange resin desalting processings, adds ASPARTIC ACID reaction, rotation Water is evaporated off, organic solvent crystallizes to obtain crude product, is refining to obtain finished product.This method is disadvantageous in that reaction needs to concentrate after terminating Water removal, it is higher to equipment requirements such as shop equipment especially drawdown pumps, while artificial increased ammoniacal liquor can be in product in crystallization processes It is middle to introduce excessive ammonium salt.
The Chinese patent CN101798275A of Chongqing Lybon Pharm -Tech Co., Ltd.'s application, ASPARTIC ACID is added L-Orn acetate aqueous solution, pH value is adjusted to 6~9 with ammoniacal liquor, decolourizes, is recrystallized to give finished product.This method organic solvent Dosage is big, and cost is of a relatively high;And the more difficult removing of ammonium acetate that generates after reacting, inevitably bring into crystalline product and Influence the purity of product.
The content of the invention
It is an object of the invention to overcome drawbacks described above, there is provided a kind of purity height and the aspartic acid ornithine of high income Preparation method, reaction condition is simple, and cost is low, be adapted to industrialized production.
In order to solve the above-mentioned technical problem, the technical solution adopted by the present invention is:
A kind of preparation method of aspartic acid ornithine, comprises the following steps,
Step 1:L-ornithine hydrochloride is mixed with water and dissolved, is subsequently added into the cation exchange tree after activation Adsorbed in fat, the cationic ion-exchange resin is then first eluted with water, and (cation for being adsorbed with L-ornithine hydrochloride is handed over Change resin) the not chloride ion-containing into leacheate, then carried out with ammoniacal liquor eluting to obtain eluent;
Step 2:Step 1 gained eluent be concentrated under reduced pressure and carries out removing ammonia, obtains free L-Orn feed liquid;
Step 3:The free L-Orn feed liquid of step 2 is mixed with ASPARTIC ACID and reacted, obtains L-aminobutanedioic acid The aqueous solution of ornithine, the aqueous solution of aspartic acid ornithine is then heated to 40~80 DEG C, it is organic to add first Solvent be incubated 1h, then crystallisation by cooling, filtering, obtain aspartic acid ornithine semifinished product, wherein the first organic solvent be methanol, One or more in ethanol, isopropanol, acetone, propane diols;
Step 4:Add water to be dissolved to the aspartic acid ornithine semifinished product of step 3, be subsequently added into activated carbon and taken off Color, then filter off except activated carbon, obtain filtrate, filtrate is heated to 40~80 DEG C, add the second organic solvent insulation 1h, so Crystallisation by cooling, filtering and drying afterwards, aspartic acid ornithine finished product is obtained, wherein the second organic solvent is methanol, ethanol, isopropyl One or more in alcohol, acetone, propane diols.
The beneficial effects of the present invention are:(1) the inventive method is effectively reduced in product without concentration water removal for a long time The generation of impurity, and then the purity of product is improved, while reduce and concentrator is depended on unduly;(2) the inventive method The step of simple, process stabilizing, reduce loss of the aspartic acid ornithine in each step, effectively increase the receipts of product Rate, it is adapted to industrial production demand;(3) the inventive method has the advantages of reaction condition is simple, cost is low, easily operated.
Embodiment
To describe the technology contents of the present invention, construction feature, the objects and the effects in detail, below in conjunction with embodiment It is explained in detail.
The design of most critical of the present invention is:Cationic ion-exchange resin is utilized by raw material of L-ornithine hydrochloride, is passed through Absorption, elution, obtain the free L-Orn aqueous solution except ammonia, the L-Orn aqueous solution and ASPARTIC ACID by reaction, Finished product is obtained after crystallization, refined rear, drying.
A kind of preparation method of aspartic acid ornithine, comprises the following steps,
Step 1:Step 1:L-ornithine hydrochloride is mixed with water and dissolved, is subsequently added into the cation after activation Adsorbed in exchanger resin, the cationic ion-exchange resin is then first eluted with water and (is adsorbed with the sun of L-ornithine hydrochloride Ion exchange resin) the not chloride ion-containing into leacheate, then carried out with ammoniacal liquor eluting to obtain eluent;
Step 2:Step 1 gained eluent be concentrated under reduced pressure and carries out removing ammonia, obtains free L-Orn feed liquid;
Step 3:The free L-Orn feed liquid of step 2 is mixed with ASPARTIC ACID and reacted, obtains L-aminobutanedioic acid The aqueous solution of ornithine, the aqueous solution of aspartic acid ornithine is then heated to 40~80 DEG C, it is organic to add first Solvent be incubated 1h, then crystallisation by cooling, filtering, obtain aspartic acid ornithine semifinished product, wherein the first organic solvent be methanol, One or more in ethanol, isopropanol, acetone, propane diols;
Step 4:Add water to be dissolved to the aspartic acid ornithine semifinished product of step 3, be subsequently added into activated carbon and taken off Color, then filter off except activated carbon, obtain filtrate, filtrate is heated to 40~80 DEG C, add the second organic solvent insulation 1h, so Crystallisation by cooling, filtering and drying afterwards, aspartic acid ornithine finished product is obtained, wherein the second organic solvent is methanol, ethanol, isopropyl One or more in alcohol, acetone, propane diols.
The present invention principle be:Chemical neutralization reaction is carried out between L-ASPARTIC ACID and L-Orn and prepares L-aminobutanedioic acid Ornithine, in preparation process two important raw materials be L-ASPARTIC ACID and L-Orn mainly with nature in the presence of Native compound purified and obtained, it is directly anti-with L-aminobutanedioic acid because L-Orn mainly exists with hydrochloride form In requisition for addition acid binding agent, and final product quality can be caused to decline, coherent detection index such as chlorion, relevant material etc. are difficult to close Lattice, need for ornithine hydrochloride to be prepared into free L-Orn for this.The invention provides a kind of ion exchange resin Method, using cationic ion-exchange resin, by adsorbing, eluting, except ammonia obtains the free L-Orn aqueous solution, L-Orn water Solution by reacting, crystallize, it is refined after, dry after obtain finished product, it is dense by the mass concentration scope control, the feed liquid that elute ammoniacal liquor The limit handling of degree and wherein ammoniacal liquor, react pH scopes, crystallized mixed solvent ratios and crystallization temperature and crystallization temperature control System etc. is further to improve the purity of product and yield.
It is involved in the present invention react chemical formula is as follows:
It was found from foregoing description, the beneficial effects of the present invention are:(1) the inventive method removes water without concentration for a long time, Effectively reduce the generation of impurity in product, and then improve the purity of product, at the same reduce to concentrator it is excessive according to Rely;(2) the step of the inventive method is simple, process stabilizing, reduces loss of the aspartic acid ornithine in each step, effectively The yield of product is improved, is adapted to industrial production demand;(3) the inventive method has that reaction condition is simple, cost is low, is easy to The advantages of operation.
Further, the mass concentration of ammoniacal liquor described in step 1 is 4~8%.
Seen from the above description, the mass concentration of ammoniacal liquor is too low, then elution effect is poor, consumes a large amount of eluents, subsequently Crystallization needs to add the raising of recrystallisation solvent volume, and the yield of finished product declines and process costs improve, too high, elution effect enhancing, But elution process heat release is obvious, while the free L-Orn concentration of gained is excessive, while greatly exacerbates impurity A (structure Formula is as follows) generation, lmpurities A is higher, and final product quality declines obvious;
Further, the temperature used is concentrated under reduced pressure in step 2 as 30~80 DEG C.
Further, temperature is 40~60 DEG C used by being concentrated under reduced pressure in step 2.
Further, the concrete operations of the step 2 are:Step 1 gained eluent be concentrated under reduced pressure and carries out removing ammonia Until the mass concentration of free ammonia is less than 0.25% in eluent, free L-Orn feed liquid is obtained.
Seen from the above description, the mass concentration for controlling free ammonia in eluent is less than 0.25%, avoids free ammonia mistake Height causes to occur in product to be difficult to the ammonium salt removed and causes product unqualified.
Further, the dissociate L-Orn concentration of dissociating in L-Orn feed liquid of rate-determining steps 2 is 100~200mg/mL.
Seen from the above description, if the concentration of free L-Orn concentration is too low, later crystallization needs can be caused to add The volume of recrystallisation solvent improves, and causes product yield to decline, and process costs improve, if the concentration mistake of free L-Orn concentration Height, required concentration time is long, causes increasing for above-mentioned impurity A, meanwhile, increase equipment energy consumption, be unfavorable for industrialization.
Further, the concrete operations of step 3 are:The free L-Orn feed liquid of step 2 is mixed with ASPARTIC ACID Close, and adjust the pH value of solution and reacted to 6~7, the aqueous solution of aspartic acid ornithine is obtained, then by L-aminobutanedioic acid bird ammonia The aqueous solution of acid is heated to 55~75 DEG C, adds the first organic solvent insulation 1h, is subsequently cooled to 20~30 DEG C of progress Crystallization, then filters, obtains aspartic acid ornithine semifinished product, wherein the first organic solvent is methanol, ethanol, isopropanol, third One or more in ketone, propane diols.
Seen from the above description, the pH value of solution is adjusted 6~7, avoids the free bird for having neither part nor lot in reaction in product being present Propylhomoserin or L-aminobutanedioic acid, the important indicator aspartic acid ornithine ratio of liquid phase HPLC monitoring is unqualified, causes final product quality not It is qualified;Control heating-up temperature to promote the dissolvings of raw material for 55~75 DEG C and crystallize to improve product quality, avoid exceeding simultaneously The boiling point of organic solvent causes bumping.
Further, first organic solvent and the second organic solvent are methanol.
Further, the weight of the dosage of second organic solvent and the dosage of water ratio is 2~4: 1 in step 4.
Seen from the above description, from methanol as first and second organic solvent, while the second organic solvent and water are controlled Weight is than to take into account the yield and purity of product simultaneously.
Embodiment 1
Step 1:100gL- ornithine hydrochlorides are dissolved in 1000g water, the SK1B cations after 10kg is activated are handed over After changing resin adsorption, SK1B cationic ion-exchange resins are washed with water to leacheate not chloride ion-containing, are then eluted with 5.0% ammoniacal liquor, The eluent of pH >=9 is collected, stops collecting when controlling elution feed concentration 15mg/mL in HPLC, obtains eluent;
Step 2:The eluent of step 1 is concentrated under reduced pressure at 50 DEG C, and except ammonia, into eluent, the mass concentration of free ammonia is 0.1%, obtain free L-Orn feed liquid, concentration 175mg/mL;
Step 3:At room temperature, ASPARTIC ACID (2.5 is slowly added portionwise into the free L-Orn feed liquid of step 2 ~2.6g/min) mixed, and the pH value for adjusting solution is 6.5, (is started to having reacted from addition ASPARTIC ACID, greatly About 30min, pH value judge that reaction is complete for no longer fluctuation), 70 DEG C are heated to, is slow added into the insulation of 956g methanol 1h, then slowly it is cooled to 25 DEG C and is crystallized and then filtered, obtain crude white solid (aspartic acid ornithine semifinished product) 138g;
Step 4:It is complete that step 3 gained aspartic acid ornithine semifinished product is added to 345g water dissolving, 2.5g is added and lives Property carbon decoloring 0.5h, then filter off except activated carbon, obtain filtrate, filtrate is heated to 70 DEG C, add 821g methanol insulation 1h, then slowly it is cooled to 25 DEG C of crystallizations, filters to obtain filter cake, filter cake is dried in vacuo under 45 DEG C of environment, obtains L-aminobutanedioic acid bird Propylhomoserin finished product 121g, the purity of aspartic acid ornithine finished product is 99.7%, aspartic acid ornithine ratio 2.77, product yield For 76.9%.
Wherein product yield is molar yield, and calculation is as follows:
Product yield (%)={ WFinished product/[(WL-ornithine hydrochloride/ 168.62) × 265.27] } × 100%
Symbol description:
WFinished product--- the weight (g) of product;WL-ornithine hydrochloride--- the weight (g) for the L-ornithine hydrochloride that feeds intake;
168.62 --- the molal weight of ornithine hydrochloride;265.27 --- finished product is mole of aspartic acid ornithine Quality.
Embodiment 2
Step 1:100gL- ornithine hydrochlorides are dissolved in 1000g water, the SK1B cations after 10kg is activated are handed over After changing resin adsorption, SK1B cationic ion-exchange resins are washed with water to leacheate not chloride ion-containing, are then eluted with 5.0% ammoniacal liquor, The eluent of pH >=9 is collected, stops collecting when controlling elution feed concentration 15mg/mL in HPLC, obtains eluent;
Step 2:The eluent of step 1 is concentrated under reduced pressure at 50 DEG C, and except ammonia, into eluent, the mass concentration of free ammonia is 0.2%, obtain free L-Orn feed liquid, concentration 164mg/mL;
Step 3:At room temperature, ASPARTIC ACID progress is slowly added portionwise into the free L-Orn feed liquid of step 2 Mixing, and the pH value for adjusting solution is 6.9, to having reacted, is heated to 70 DEG C, is slow added into 1018g methanol insulation 1h, Then slowly it is cooled to 25 DEG C and is crystallized and then filtered, obtains crude white solid (aspartic acid ornithine semifinished product) 129g;
Step 4:It is complete that step 3 gained aspartic acid ornithine semifinished product is added to 323g water dissolving, 2.5g is added and lives Property carbon decoloring 0.5h, then filter off except activated carbon, obtain filtrate, filtrate is heated to 70 DEG C, add 768g methanol insulation 1h, then slowly it is cooled to 25 DEG C of crystallizations, filters to obtain filter cake, filter cake is dried in vacuo under 45 DEG C of environment, obtains L-aminobutanedioic acid bird Propylhomoserin finished product 119g, the purity of aspartic acid ornithine finished product is 99.8%, aspartic acid ornithine ratio 2.81, product yield For 75.6% (computational methods are with embodiment 1).
Embodiment 3
Step 1:100gL- ornithine hydrochlorides are dissolved in 1000g water, the JK006 gel-types sun after 10kg is activated After ion exchange resin absorption, JK006 gel-network precipitation methods (being adsorbed with ornithine hydrochloride) are washed with water to elution Liquid not chloride ion-containing, then eluted with 5.0% ammoniacal liquor, collect the eluent of pH >=9, control elution feed concentration 15mg/ in HPLC Stop collecting during mL, obtain eluent;
Step 2:The eluent of step 1 is concentrated under reduced pressure at 50 DEG C, and except ammonia, into eluent, the mass concentration of free ammonia is 0.1%, obtain free L-Orn feed liquid, concentration 185mg/mL;
Step 3:At room temperature, ASPARTIC ACID progress is slowly added portionwise into the free L-Orn feed liquid of step 2 Mixing, and the pH value for adjusting solution is 6.5, to having reacted, is heated to 70 DEG C, is slow added into 867g methanol insulation 1h, Then slowly it is cooled to 25 DEG C and is crystallized and then filtered, obtains crude white solid (aspartic acid ornithine semifinished product) 136g;
Step 4:It is complete that step 3 gained aspartic acid ornithine semifinished product is added to 340g water dissolving, 2.5g is added and lives Property carbon decoloring 0.5h, then filter off except activated carbon, obtain filtrate, filtrate is heated to 70 DEG C, add 809g methanol insulation 1h, then slowly it is cooled to 25 DEG C of crystallizations, filters to obtain filter cake, filter cake is dried in vacuo under 45 DEG C of environment, obtains L-aminobutanedioic acid bird Propylhomoserin finished product 120g, the purity of aspartic acid ornithine finished product is 99.5%, aspartic acid ornithine ratio 2.79, product yield For 76.3% (computational methods are with embodiment 1).
Embodiment 4
Step 1:100g ornithine hydrochlorides are dissolved in 1000g water, the SK1B gel-types sun after 10kg is activated from After sub-exchange resin absorption, SK1B gel-network precipitation methods (being adsorbed with ornithine hydrochloride) are washed with water to leacheate not Chloride ion-containing, then eluted with 5.0% ammoniacal liquor, the eluent of pH >=9 is collected, when elution feed concentration 15mg/mL is controlled in HPLC Stop collecting, obtain eluent;
Step 2:The eluent of step 1 is concentrated under reduced pressure at 50 DEG C, and except ammonia, into eluent, the mass concentration of free ammonia is 0.1%, obtain free L-Orn feed liquid, concentration 159mg/mL;
Step 3:At room temperature, ASPARTIC ACID progress is slowly added portionwise into the free L-Orn feed liquid of step 2 Mixing, and the pH value for adjusting solution is 6.0, to having reacted, is heated to 70 DEG C, is slow added into 1123g methanol insulation 1h, Then slowly it is cooled to 25 DEG C and is crystallized and then filtered, obtains crude white solid (aspartic acid ornithine semifinished product) 142g;
Step 4:It is complete that step 3 gained aspartic acid ornithine semifinished product is added to 355g water dissolving, 2.5g is added and lives Property carbon decoloring 0.5h, then filter off except activated carbon, obtain filtrate, filtrate is heated to 70 DEG C, add 845g methanol insulation 1h, then slowly it is cooled to 25 DEG C of crystallizations, filters to obtain filter cake, filter cake is dried in vacuo under 45 DEG C of environment, obtains L-aminobutanedioic acid bird Propylhomoserin finished product 123g, the purity of aspartic acid ornithine finished product is 99.6%, aspartic acid ornithine ratio 2.92, product yield For 78.2% (computational methods are with embodiment 1).
In summary, the preparation method of aspartic acid ornithine provided by the invention, removed water without long-time concentration, effectively The generation of impurity in product is reduced, and then improves the purity of product, while reduces and concentrator is depended on unduly;This The step of inventive method, is simple, process stabilizing, reduces loss of the aspartic acid ornithine in each step, effectively increases production The yield of product, it is adapted to industrial production demand;The inventive method has the advantages of reaction condition is simple, cost is low, easily operated.
Embodiments of the invention are the foregoing is only, are not intended to limit the scope of the invention, it is every to utilize this hair The equivalent structure or equivalent flow conversion that bright description is made, or directly or indirectly it is used in other related technology necks Domain, it is included within the scope of the present invention.

Claims (8)

  1. A kind of 1. preparation method of aspartic acid ornithine, it is characterised in that comprise the following steps,
    Step 1:L-ornithine hydrochloride is mixed with water and dissolved, is subsequently added into cationic ion-exchange resin and is inhaled It is attached, cationic ion-exchange resin not chloride ion-containing into leacheate is first eluted with water, then carried out with ammoniacal liquor eluting to obtain eluent;
    Step 2:Step 1 gained eluent be concentrated under reduced pressure and carries out removing ammonia, obtains free L-Orn feed liquid;
    Step 3:The free L-Orn feed liquid of step 2 is mixed with ASPARTIC ACID and reacted, obtains L-aminobutanedioic acid bird ammonia The aqueous solution of acid, is then heated to 40~80 DEG C by the aqueous solution of aspartic acid ornithine, adds the first organic solvent 1h is incubated, then crystallisation by cooling, filtering, obtain aspartic acid ornithine semifinished product, wherein the first organic solvent is methanol, second One or more in alcohol, isopropanol, acetone, propane diols;
    Step 4:Add water to be dissolved to the aspartic acid ornithine semifinished product of step 3, be subsequently added into activated carbon and decolourized, so After filter off except activated carbon, obtain filtrate, filtrate be heated to 40~80 DEG C, add the second organic solvent insulation 1h, Ran Houleng But crystallize, filter and dry, obtain aspartic acid ornithine finished product, wherein the second organic solvent be methanol, ethanol, isopropanol, One or more in acetone, propane diols.
  2. 2. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that ammoniacal liquor described in step 1 Mass concentration be 4~8%.
  3. 3. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that be concentrated under reduced pressure in step 2 The temperature used is 30~80 DEG C.
  4. 4. the preparation method of aspartic acid ornithine according to claim 3, it is characterised in that be concentrated under reduced pressure in step 2 Used temperature is 40~60 DEG C.
  5. 5. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that the step 2 it is specific Operate and be:Step 1 gained eluent be concentrated under reduced pressure and carried out except ammonia until the mass concentration of free ammonia is in eluent Less than 0.25%, obtain free L-Orn feed liquid.
  6. 6. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that the concrete operations of step 3 For:The free L-Orn feed liquid of step 2 is mixed with ASPARTIC ACID, and the pH value for adjusting solution is anti-to 6~7 progress Should, the aqueous solution of aspartic acid ornithine is obtained, the aqueous solution of aspartic acid ornithine is then heated to 55~75 DEG C, then The first organic solvent insulation 1h is added, 20~30 DEG C is subsequently cooled to and is crystallized, then filter, obtain aspartic acid ornithine Semifinished product, wherein the first organic solvent is the one or more in methanol, ethanol, isopropanol, acetone, propane diols.
  7. 7. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that first organic solvent It is methanol with the second organic solvent.
  8. 8. the preparation method of aspartic acid ornithine according to claim 1, it is characterised in that second is organic in step 4 The weight of the dosage of solvent and the dosage of water ratio is 2~4: 1.
CN201710945408.XA 2017-10-12 2017-10-12 A kind of preparation method of aspartic acid ornithine Pending CN107522629A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710945408.XA CN107522629A (en) 2017-10-12 2017-10-12 A kind of preparation method of aspartic acid ornithine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710945408.XA CN107522629A (en) 2017-10-12 2017-10-12 A kind of preparation method of aspartic acid ornithine

Publications (1)

Publication Number Publication Date
CN107522629A true CN107522629A (en) 2017-12-29

Family

ID=60684499

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710945408.XA Pending CN107522629A (en) 2017-10-12 2017-10-12 A kind of preparation method of aspartic acid ornithine

Country Status (1)

Country Link
CN (1) CN107522629A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108840805A (en) * 2018-08-03 2018-11-20 安徽省金楠医疗科技有限公司 Aspartic acid ornithine synthetic method
CN110317144A (en) * 2018-03-28 2019-10-11 上海贵之言医药科技有限公司 A kind of aspartic acid ornithine Crystal form of double salt compound and preparation method thereof
CN114349652A (en) * 2021-12-10 2022-04-15 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101844995A (en) * 2010-05-13 2010-09-29 上海李氏化学科技有限公司 Preparation method of L-ornithine-L-aspartate
CN103864634A (en) * 2014-03-27 2014-06-18 常州兰陵制药有限公司 Method for preparing ornithine aspartate
CN103936611A (en) * 2013-01-23 2014-07-23 大同长兴制药有限责任公司 Preparation method for ornithine aspartate
CN104058981A (en) * 2013-03-18 2014-09-24 辽宁科泰生物基因制药股份有限公司 Preparation method of ornithine aspartate
CN104649920A (en) * 2013-11-18 2015-05-27 北京众和民健医药科技有限公司 Method for preparing ornithine aspartate
CN104774158A (en) * 2015-02-12 2015-07-15 肖文辉 Novel preparation method for ornithine aspartate
CN105154499A (en) * 2015-09-30 2015-12-16 精晶药业股份有限公司 Preparation method of L-aspartate-L-ornithine
CN105152951A (en) * 2015-07-17 2015-12-16 宁波海硕药业科技有限公司 Preparation method for L-ornithine*L-aspartic acid

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101844995A (en) * 2010-05-13 2010-09-29 上海李氏化学科技有限公司 Preparation method of L-ornithine-L-aspartate
CN103936611A (en) * 2013-01-23 2014-07-23 大同长兴制药有限责任公司 Preparation method for ornithine aspartate
CN104058981A (en) * 2013-03-18 2014-09-24 辽宁科泰生物基因制药股份有限公司 Preparation method of ornithine aspartate
CN104649920A (en) * 2013-11-18 2015-05-27 北京众和民健医药科技有限公司 Method for preparing ornithine aspartate
CN103864634A (en) * 2014-03-27 2014-06-18 常州兰陵制药有限公司 Method for preparing ornithine aspartate
CN104774158A (en) * 2015-02-12 2015-07-15 肖文辉 Novel preparation method for ornithine aspartate
CN105152951A (en) * 2015-07-17 2015-12-16 宁波海硕药业科技有限公司 Preparation method for L-ornithine*L-aspartic acid
CN105154499A (en) * 2015-09-30 2015-12-16 精晶药业股份有限公司 Preparation method of L-aspartate-L-ornithine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317144A (en) * 2018-03-28 2019-10-11 上海贵之言医药科技有限公司 A kind of aspartic acid ornithine Crystal form of double salt compound and preparation method thereof
CN108840805A (en) * 2018-08-03 2018-11-20 安徽省金楠医疗科技有限公司 Aspartic acid ornithine synthetic method
CN114349652A (en) * 2021-12-10 2022-04-15 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate
CN114349652B (en) * 2021-12-10 2024-03-29 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate

Similar Documents

Publication Publication Date Title
CN107522629A (en) A kind of preparation method of aspartic acid ornithine
CN105348154B (en) The recovery method of sulfosalicylic acid in a kind of Doxycycline production waste liquid
CN101798275B (en) Method for preparing L-ornithine-L aspartate
WO2011041935A1 (en) Method for extracting citric acid and/or sodium citrate from fermented solution
EP1927586B1 (en) Process for producing 5-aminolevulinic acid hydrochloride
CN104672310A (en) Preparation method of vancomycin hydrochloride
CN104231016A (en) Etimicin sulfate preparation method
CN111574559A (en) Post-treatment method of L-glufosinate-ammonium enzyme hydrolysate
CN106946722B (en) A kind of deuterium exchange synthesis L-Aspartic acid (3,3-D2) method
CN101987736A (en) Preparation method of high-purity strontium carbonate
CN101624351A (en) Preparation method of DL-lysine
CN111056941B (en) Method for preparing high-purity shikimic acid by utilizing ginkgo leaf extract chromatography waste liquid
CN103204522A (en) Preparation method of high-purity mass potassium nitrate
CN1539815A (en) Method for preparing gabapentin
NO147671B (en) PROCEDURE FOR PREPARING 2-DEUTERO-3-FLUOR-DL-ALANIN
CN108752230B (en) Synthesis method of key intermediate of contrast agent iodixanol impurity E
CN104496833A (en) Gabapentin synthesis technology
CN104177271A (en) Method for preparing acetyl levocarnitine hydrochloride
CN115894553B (en) Method for separating and purifying glufosinate
CN112552164B (en) Process method for extracting malic acid from unqualified sodium citrate mother liquor
CN105271366A (en) Superior pure zinc sulfate preparation method
CN103772224B (en) Preparation method of D-threonine
CN100494172C (en) Method of preparing 2-chloro-3-nitro-5-carboxyl benzenesulfonamide
CN113024421B (en) Purification method of p-toluenesulfonic acid iron solution
CN110172038B (en) Process for preparing analgin magnesium by one-pot method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20171229